Canada NewsWire
MISSISSAUGA, Ontario, Nov. 2, 2016
MISSISSAUGA, Ontario, Nov. 2, 2016 /CNW/ -- Aralez
Pharmaceuticals Inc. (NASDAQ: ARLZ) (TSX: ARZ), a global specialty pharmaceutical company, today announced that executive
management will participate in the Jefferies London Healthcare Conference to be held November 16-17,
2016. Adrian Adams, Chief Executive Officer, will provide an overview of the Company at
4:40 p.m. local time on Wednesday, November 16, 2016.
A live webcast and audio archive for the event may be accessed from the Investors section of the Aralez website at www.aralez.com. Please connect to the website prior to the start of the
presentation to ensure adequate time for any software downloads that may be necessary to listen to the webcast.
About Aralez Pharmaceuticals Inc.
Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ and TSX: ARZ) is a global specialty pharmaceutical company focused on
delivering meaningful products to improve patients' lives while creating shareholder value by acquiring, developing and
commercializing products primarily in cardiovascular, pain and other specialty areas. Aralez's Global Headquarters is in
Ontario, Canada, the US Headquarters is planned to be in Princeton,
NJ and the Irish Headquarters is in Dublin, Ireland. More information about Aralez can be
found at www.aralez.com.
Contact Information:
Aralez Pharmaceuticals US Inc.
Nichol Ochsner
Executive Director,
Investor Relations & Corporate Communications
732.754.2545
nochsner@aralez.com
Logo - http://photos.prnewswire.com/prnh/20161001/414159LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/aralez-to-present-at-the-jefferies-london-healthcare-conference-300355651.html
SOURCE Aralez Pharmaceuticals Inc.
